Cardiovascular Systems, Inc. v. Gary Petrucci ( 2022 )


Menu:
  •                 United States Court of Appeals
    For the Eighth Circuit
    ___________________________
    No. 21-1827
    ___________________________
    Cardiovascular Systems, Inc.
    Plaintiff - Appellant
    v.
    Gary Petrucci; Lela Nadirashvili
    Defendants - Appellees
    ____________
    Appeal from United States District Court
    for the District of Minnesota
    ____________
    Submitted: March 15, 2022
    Filed: June 14, 2022
    [Unpublished]
    ____________
    Before ERICKSON, GRASZ, and STRAS, Circuit Judges.
    ____________
    PER CURIAM.
    After Cardio Flow developed a new medical device, its owners were sued by
    Cardiovascular Systems for allegedly breaching an eight-year-old settlement
    agreement. The district court 1 concluded that two of the claims were filed too late
    and another one failed to identify an actual breach. We affirm.
    I.
    Over a decade ago, Dr. Leonid Shturman invented a new device to treat
    coronary and peripheral artery disease. When he tried to patent it, his former
    employer, Cardiovascular Systems, claimed that it owned the invention. After he
    died, whatever interest he had in the contested intellectual property passed to his
    wife, Lela Nadirashvili.
    The parties eventually settled and agreed to split the patents: Cardiovascular
    Systems received some and Nadirashvili received the others. The idea was that
    Cardiovascular Systems could use its patents to develop a solid-counterweight
    device and Nadirashvili could use her own to build a fluid-counterweight device. To
    deal with any potential overlap, each side gave the other an exclusive license to the
    other’s patents, meaning that each had the ability to access the whole patent portfolio
    when creating their own devices.
    The settlement agreement was just as complicated as it sounds. One
    complication arose when Nadirashvili sold her patents to a third party, Cardio Flow,
    in exchange for $50,000 and a 40% stake in the company, with the other 60% owned
    by Gary Petrucci. According to Cardiovascular Systems, the sale violated the
    settlement agreement because Cardio Flow never agreed in writing “to be bound to
    [the] [a]greement as if it were a party.” To the extent Petrucci facilitated the breach,
    Cardiovascular Systems wanted to hold him responsible too.
    The second alleged breach came a few years later, when Cardio Flow
    developed its FreedomFlow device. This time, the allegation is that Petrucci directly
    1
    The Honorable Susan Richard Nelson, United States District Judge for the
    District of Minnesota.
    -2-
    orchestrated a breach by having Cardio Flow design a solid-counterweight device—
    the exact type of technology that Cardiovascular Systems had the exclusive right to
    develop under the settlement agreement.
    Based on these two theories, Cardiovascular Systems sued each of the owners
    of Cardio Flow: Nadirashvili for breach of the settlement agreement and Petrucci for
    tortiously interfering with it. The district court dismissed the case after concluding
    that the claims arising out of the first breach were filed beyond the statute of
    limitations and the rest did not state a claim. See Fed. R. Civ. P. 12(b)(6).
    II.
    Delay dooms the first set of claims. Minnesota law requires breach-of-
    contract actions to be filed within six years of the date of accrual. See 
    Minn. Stat. §§ 541.01
    , 541.05, subdiv. 1(1); see also Antone v. Mirviss, 
    720 N.W.2d 331
    , 336
    (Minn. 2006) (explaining that the “running of the statute of limitations” starts upon
    “accrual of the cause of action”). The parties disagree about the exact date of
    accrual, but the underlying facts are undisputed. Cardiovascular Systems did not
    sue until 2020, nearly eight years after Nadirashvili sold her patents to Cardio Flow.
    The claims can only be timely, in other words, if they accrued after the sale.
    A.
    There is no mystery about when breach-of-contract actions accrue in
    Minnesota. See Nettles v. Am. Tel. & Tel. Co., 
    55 F.3d 1358
    , 1362 (8th Cir. 1995)
    (explaining that in diversity cases, federal courts “apply the law of the forum when
    ruling on statutes of limitations” (citing Guar. Tr. Co. v. York, 
    326 U.S. 99
    , 108–09
    (1945)). According to the Minnesota Supreme Court, they accrue “at the time of the
    breach [itself], even if ‘actual damages resulting therefrom do not occur until
    afterwards.’” Park Nicollet Clinic v. Hamann, 
    808 N.W.2d 828
    , 832 (Minn. 2011)
    (quoting Bachertz v. Hayes-Lucas Lumber Co., 
    275 N.W. 694
    , 697 (Minn. 1937)).
    -3-
    This straightforward rule produces a straightforward result here. The breach
    happened, and the claim accrued, when Nadirashvili failed to get Cardio Flow to
    agree in writing in 2012 that it would be “bound to [the] [a]greement as if it were a
    party.” Filing the action nearly eight years later, in 2020, was simply too late.
    B.
    The same goes for the tortious-interference-with-contract claim against
    Petrucci. Under Minnesota law, the nature of the underlying cause of action
    determines the applicable statute of limitations. See Wild v. Rarig, 
    234 N.W.2d 775
    ,
    793 (Minn. 1975) (per curiam). Here, the tortious-interference claim “stems from
    and grew out of” Nadirashvili’s alleged breach of the settlement agreement, so the
    same six-year statute of limitations applies. 
    Id.
     The accrual date is also the same,
    meaning that Cardiovascular Systems was late in filing this claim as well.2 See Park
    Nicollet, 808 N.W.2d at 832.
    III.
    The other tortious-interference claim against Petrucci fares no better. This
    one is based on his role in getting Nadirashvili to breach the settlement agreement
    by having Cardio Flow develop a solid-counterweight device. See Kallok v.
    Medtronic, Inc., 
    573 N.W.2d 356
    , 362 (Minn. 1998) (explaining that “intentional
    procurement of [a] breach” is an element of a tortious-interference claim (quoting
    Kjesbo v. Ricks, 
    517 N.W.2d 585
    , 588 (Minn. 1994)).
    2
    Even if the tortious-interference claim accrued only after Cardiovascular
    Systems suffered damages, see Kallok v. Medronic, Inc., 
    573 N.W.2d 356
    , 363
    (Minn. 1998), the clock started when Nadirashvili’s assignment allegedly caused
    Cardiovascular Systems to lose its “rights to the patents.” See Antone, 720 N.W.2d
    at 338 (explaining that the plaintiff suffered damages when he entered a marriage
    and “lost the legal right to unfettered ownership of his premarital property” under a
    faulty prenuptial agreement).
    -4-
    Even if Cardiovascular Systems is right that Nadirashvili agreed not to design
    such a device, it still has not identified a breach of the settlement agreement. Cardio
    Flow built the device, and nothing committed her to, in the district court’s words,
    “indefinitely and proactively prevent[ing] third parties from infringing the assigned
    patents.” 3 And without an underlying breach, Petrucci cannot be liable under a
    tortious-interference theory. See id.
    IV.
    We accordingly affirm the judgment of the district court and deny the pending
    motion for judicial notice.
    ______________________________
    3
    Cardiovascular Systems has made no mention of the underlying breach-of-
    contract claim against Nadirashvili on appeal. See Jenkins v. Winter, 
    540 F.3d 742
    ,
    751 (8th Cir. 2008) (“Claims not raised in an opening brief are deemed waived.”).
    But even if it had, it would fail for the same reason as the claim against Petrucci.
    -5-
    

Document Info

Docket Number: 21-1827

Filed Date: 6/14/2022

Precedential Status: Non-Precedential

Modified Date: 6/14/2022